Recombinant BTLA (Tifcemalimab Biosimilar) antibody
The Chimeric Chimeric anti-BTLA (Tifcemalimab Biosimilar) antibody (ABIN7598039) specifically detects BTLA (Tifcemalimab Biosimilar).
The antibody is reactive with Human samples.
Catalog No. ABIN7598039
$357.68
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 15 Business Days
Quick Overview for Recombinant BTLA (Tifcemalimab Biosimilar) antibody (ABIN7598039)
Target
BTLA (Tifcemalimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Chimeric
Clonality
Chimeric
Conjugate
This BTLA (Tifcemalimab Biosimilar) antibody is un-conjugated
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Tifcemalimab Biosimilar Antibody
-
Specificity
- B- and T-lymphocyte attenuator, BTLA, CD272, B- and T-lymphocyte-associated protein
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG4 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 2.61 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- BTLA (Tifcemalimab Biosimilar)
-
Alternative Name
- Tifcemalimab Biosimilar
-
Target Type
- Biosimilar
-
Background
- B- and T-lymphocyte attenuator, BTLA, CD272, B- and T-lymphocyte-associated protein
-
UniProt
- Q7Z6A9
-
CAS-No
- 2236068-83-8
Target
-
You are here:
